Drug patents …
… from Kazakhstan to Kalamazoo
Proactively manage your pharmacy inventory
Anticipate generic drug launch
Manage your formulary budget
Find generic entry opportunities
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Title:||Epipodophyllotoxin glucoside 4'-phosphate derivatives|
|Abstract:||Phosphate derivatives of 4'-demethylepipodophyllotoxin glucosides are novel antitumor agents and the salts thereof offer the pharmaceutical advantage of high water solubility.|
|Inventor(s):||Saulnier; Mark G. (Middletown, CT), Senter; Peter D. (Northeast Seattle, WA), Kadow; John F. (Wallingford, CT)|
|Assignee:||Bristol-Myers Squibb Company (New York, NY)|
Patent Claim Types:|
see list of patent claims
|Compound; Composition; Process;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|United Kingdom||2207674||► subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.